Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically - Trial NCT06370780
Access comprehensive clinical trial information for NCT06370780 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, Los Angeles and is currently Recruiting. The study focuses on HIV Infections. Target enrollment is 1000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of California, Los Angeles
Timeline & Enrollment
N/A
Feb 09, 2024
Apr 30, 2025
Primary Outcome
Incidence of HIV Viral Suppression,Level of Adherence to HIV medication,Level of Adherence based on HIV appointments
Summary
Despite the widespread availability of effective antiretroviral therapy (ART) in the United
 States, there remains significant numbers of people living with HIV (PLWH) who fail to
 achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of
 VS among Black individuals, people who use drugs, youth ages 18-24 and people residing in
 rural areas. Investigators will examine the syndemics underlying these outcomes including
 substance use, mental health, and barriers to HIV care including racial discrimination,
 stigma and rural isolation.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06370780
Non-Device Trial